AccuRx

AccuRx is a British software company that has developed a messaging service for doctor surgeries to communicate with patients.[1]

The company was co-founded by Jacob Haddad and Laurence Bargery, who met and subsequently founded the company at Entrepreneur First in 2016.[2]

Accurx's main product is Chain SMS, a messaging program used by doctor surgeries to communicate with patients.[2][3] The program runs on desktop computers and sends SMS text messages.[4] It can integrate with some software used in GP surgeries[4]SystmOne and EMIS Health.[5] Chain SMS was launched in February 2018 and as of February 2019 was used in more than 1,400 GP surgeries in the UK.[4] Since the COVID-19 pandemic in the UK, AccuRx integrated a videotelephony system into Chain SMS,[6] using Whereby,[7] and subsequently "more than 90 percent of primary care clinics in England are now using it" for online appointments.[8]

References

  1. Browne, Ryan (9 April 2020). "Demand for telemedicine has exploded in the UK as doctors adapt to the coronavirus crisis". CNBC. Retrieved 2020-04-20.
  2. "Accurx raises £8.8M Series A for its messaging app for medical teams and patients". TechCrunch. Retrieved 2020-04-19.
  3. Thornton, Jacqui (30 March 2020). "Covid-19: how coronavirus will change the face of general practice forever". BMJ. 368. doi:10.1136/bmj.m1279. ISSN 1756-1833. PMID 32229477.
  4. Field, Matthew (24 February 2019). "Start-up that sends text messages for GPs secures £9m". The Telegraph. ISSN 0307-1235. Retrieved 2020-04-19 via www.telegraph.co.uk.
  5. "AccuRx". Accurx. Retrieved 2020-04-19.
  6. Naughton, John (18 April 2020). "When Covid-19 has done with us, what will be the new normal?". The Guardian. ISSN 0261-3077. Retrieved 2020-04-19 via www.theguardian.com.
  7. "Video consultations: IG and Security". Accurx.com. Retrieved 2020-04-19.
  8. Mueller, Benjamin (4 April 2020). "Telemedicine Arrives in the U.K.: '10 Years of Change in One Week'". The New York Times. ISSN 0362-4331. Retrieved 2020-04-19 via NYTimes.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.